Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Debt Ratio
2.16%
Quarterly · Period ending:
LCTX Debt Ratio
Latest reported2.16%period ending
Latest reported2.16%period ending
LCTX Quarterly Debt Ratio (0.00% → 2.16%)
Latest values, visible window
High-resolution chart · PNG
LCTX debt ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Debt Ratio |
|---|---|
| 2.1644% | |
| 2.1856% | |
| 2.1486% | |
| 2.924% | |
| 2.3723% | |
| 2.008% | |
| 2.2205% | |
| 2.847% | |
| 2.8706% | |
| 2.9995% | |
| 2.9222% | |
| 2.9015% | |
| 3.0478% | |
| 3.2136% | |
| 3.1505% | |
| 2.135% | |
| 1.545% | |
| 1.7693% | |
| 1.6053% | |
| 2.0707% | |
| 2.1528% | |
| 2.7766% | |
| 3.5433% | |
| 2.7549% | |
| 4.0855% | |
| 4.0654% | |
| 4.1187% | |
| 3.9946% | |
| 3.2131% | |
| 2.7711% | |
| 2.228% | |
| 0.2334% | |
| 1.2258% | |
| 1.2972% | |
| 0.8849% | |
| 0.649% | |
| 2.1075% | |
| 1.8079% | |
| 2.793% | |
| 2.1609% | |
| 2.5401% | |
| 7.7028% | |
| 5.3909% | |
| 6.1841% | |
| 4.5597% | |
| 1.1559% | |
| 0.7036% | |
| 0.1897% | |
| 0.1743% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 1.4618% | |
| 57.3001% | |
| 207.501% | |
| 182.1127% | |
| 267.425% | |
| 315.7076% | |
| 232.7333% | |
| 409.2112% | |
| 570.562% | |
| 152.6888% | |
| 27.274% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 250.6094% | |
| 188.7509% | |
| 278.8135% | |
| 162.5613% | |
| 144.9657% | |
| 104.0361% | |
| 264.0469% | |
| 143.959% | |
| 89.1699% | |
| 140.5356% |